Consistent with evidence that ER can mediate glutamine metabolism in HR+ breast cancer, a number of studies have reported that ERα and/or other commonly activated oncogenes in ER+ breast cancer, including MYC, can directly or indirectly induce expression of CAD [107]. This evidence concerns the gene MYC and breast carcinoma.